Taken together with the increase of citrate, which has been previously reported (Fig
29.KOMBOGLYZE saxagliptin and metformin hydrochloride tablets (as saxagliptin hydrochloride and metformin hydrochloride) 2.5mg/500mg, 2.5mg/850mg, 2.5mg/1000mg [product monograph]
These are offered as plausible mechanisms rather than established findings, and no supporting research is cited
Verify the mg/ml on your vial label and compare it to the concentration listed on whatever chart your pharmacy provided
Their concerns were categorized as follows: Overprescribing (clinically inappropriate prescribing): 56% Compromised continuity of care (e.g., follow-up visits, titration, tapering off medication): 50% Lack of complete medical history: 47% Medication interactions and/or side effect management: 43% Lack of transparency to the patients broader care team: 32% Prevalence of compounded GLP-1s/GIPs: 32% Lack of holistic support of weight management: 24% Researchers have raised marketing and safety concerns about compounded and counterfeit GLP-1s, and the FDA recommends that patients "obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy." However, patient demand for these drugs is likely to persist due to their significantly lower costs
